Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Annals of Intensive Care

Fig. 3

From: Impact of oversedation prevention in ventilated critically ill patients: a randomized trial—the AWARE study

Fig. 3

Cumulative incidence of deaths in the hospital. The cumulative incidence of hospital death did not differ significantly between the two groups (220 in oversedation prevention group vs. 253 in the control group): hazard ratio for the oversedation prevention group versus the control group, 0.85; 95% confidence interval, 0.71–1.01; p = 0.06. For the analysis of time from randomization to death in the hospital, alive hospital discharge was handled as a competing risk

Back to article page